Literature DB >> 10226945

Infrequent p53 mutations in patients with areca quid chewing-associated oral squamous cell carcinomas in Taiwan.

M Y Kuo1, J S Huang, H C Hsu, C P Chiang, S H Kok, Y S Kuo, C Y Hong.   

Abstract

Mutations in the conserved regions (exons 5-9) of the p53 gene were investigated in 37 untreated human primary oral squamous cell carcinomas (SCCs) using polymerase chain reaction-single strand conformation polymorphism and DNA sequencing analyses. P53 mutations were detected in 2 of 37 (5.4%) oral SCC cases. One tumor sample (case 23) showed a mis-sense point mutation at codon 177, changing CCC to CTC, which resulted in a substitution of proline to leucine in the p53 protein. The other tumor (case 33) had a point mutation at codon 266, changing GGA to AGA and causing a substitution of glycine to arginine in the p53 protein. These two patients with p53 mutations did not have an areca quid chewing habit. These results suggest that mutations in the p53 gene may not play a role in the pathogenesis of human oral SCCs in Taiwan. Recently, we have shown that positive p53 staining was observed in 47 of 81 (58%) cases of oral SCC. The discrepancies between positive p53 protein staining and the low prevalence of p53 mutation in oral SCCs indicate that other mechanism(s) are involved in p53 overexpression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226945     DOI: 10.1111/j.1600-0714.1999.tb02028.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  2 in total

1.  Consistent administration of cetuximab is associated with favorable outcomes in recurrent/metastatic head and neck squamous cell carcinoma in an endemic carcinogen exposure area: a retrospective observational study.

Authors:  Hui-Ching Wang; Pei-Lin Liu; Pei-Chuan Lo; Yi-Tzu Chang; Leong-Perng Chan; Tsung-Jang Yeh; Hui-Hua Hsiao; Shih-Feng Cho
Journal:  PeerJ       Date:  2020-09-10       Impact factor: 2.984

2.  Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India.

Authors:  Sanjay Katiyar; B K Thelma; N S Murthy; Suresh Hedau; Neeraj Jain; V Gopalkrishna; Syed Akhtar Husain; Bhudev C Das
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.